Effects of Ojeoksangamibang on the Lipid Metabolism, Anti-oxidation and Concentration of Proinflammatory Cytokines in Rat Fed High Fat Diet

오적산가미방(五積散加味方)이 고지방식이 유도 비만쥐의 지질대사, 항산화계 및 전염증성 cytokine 생산에 미치는 영향

  • Kong, In-Pyo (Dept. of Oriental Rehabilitation Medicine, College of Oriental Medicine, Sang-Ji University) ;
  • Park, Won-Hyung (Dept. of Oriental Rehabilitation Medicine, College of Oriental Medicine, Sang-Ji University) ;
  • Cha, Yun-Yeop (Dept. of Oriental Rehabilitation Medicine, College of Oriental Medicine, Sang-Ji University)
  • 공인표 (상지대학교 한의과대학 한방재활의학과) ;
  • 박원형 (상지대학교 한의과대학 한방재활의학과) ;
  • 차윤엽 (상지대학교 한의과대학 한방재활의학과)
  • Received : 2011.08.17
  • Accepted : 2011.10.11
  • Published : 2011.10.30

Abstract

Objectives: This study was designed to examine the effects of extracts of Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) on the lipid lowering, anti-oxidation and concentration of proinflammatory cytokines and was investigated on hyperlipidemic rats. Methods: Male rats weighing $182.39{\pm}4.71g$ were fed high fat diet for 8 weeks and 36 rats(above 400 g) were divided into 4 groups. Each of 9 rats was divided a control group and experimental groups. We fed a control group of rats a basal diet and administered normal saline(100 mg/kg, 1 time/1 day) for 4 weeks. And we fed each experimental group of rats basal diet and administered an extract of Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) extracts(100 mg/kg, 200mg/kg, 300 mg/kg, 300 mg/kg, 1 time/1 day) for 4 weeks. At the end of the experiment, the rats were sacrificed to determine their chemical composition. We measured lipid of plasma and liver, concentration of proinflmmatory cytokines, anti-oxidative activity and $TNF-{\alpha}$, Apo-B, Apo-E and leptin gene expression. Results: 1. Concentration of plasma free fatty(FFA) showed no significant difference in all the treatment groups. Concentration of plasma triglyceride(TG) showed a significant decrement in the 300 mg/kg in Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) groups than that of control group. 2. Concentration of plasma total cholesterol showed a significant decrement in the 200 and 300 mg/kg in Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) groups than that of control group. Concentration of plasma low density lipoprotein(LDL)-cholesterol showed a Significant decrement in the 300 mg/kg in Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) groups than that of control group. Concentration of plasma high density lipoprotein(HDL)-cholesterol showed a significant increment in the 300 mg/kg in Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) group. 3. Concentration of liver total cholesterol showed a tendence to decrease in Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) groups. Concentration of liver TG showed a significant decrement in all Ojeoksangamibang groups than that of control group. 4. Concentration of plasma and liver thiobarbituric acid reactive substance(TBARS) showed a tendence to decrease in Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) groups. 5. The values of glutathione peroxidase(GSH-Px), superoxide dismutase(SOD) and catalase(CAT) activity showed a significant increment in all Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) groups than that of control group. 6. The values of plasma aspartate aminotransferase(AST) and alanine aminotransferase(ALT) activity showed no significant different in all treatment group. 7. Concentration of plasma $interleukin(IL)-1{beta}$ showed no significant difference in all the treatment groups. Concentration of plasma IL-6 showed a significant decrement in the 300 mg/kg in Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) group than that of control group. Concentration of plasma tumor necrosis $factor-{\alpha}(TNF-{\alpha})$ a siginifant decrement in the 200 and 300 mg/kg in Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) group than that of control group. However the concentration of plasma IL-10 in the 300 mg/kg Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) groups showed a significant increment than that of control group. 9. In the analysis of reverse transcription-polymerase chain reaction(RT-PCR), gene expression of $TNF-{\alpha}$, Apo-B and Apo-E in the Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) groups showed a lower expression than that of control group. However the gene expression of leptin showed no difference in the treatment groups. 10. The ratio of $TNF-{\alpha}$, Apo-B, and Apo-E per ${\beta}-actin$ expression in the Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) groups showed a significant decrement than that of control group. However The ratio of leptin expression per ${\beta}-actin$ expression showed no significant difference among all the treatment groups. Conclusions: According to above results, in lowering lipid effect, anti-oxidation and control of pro-inflammatory cytokines production, Ojeoksangamibang($W{\check{u}}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) gives effect.

Acknowledgement

Supported by : 상지대학교

References

  1. Fruhbeck G. The adipose tissue as a source of vasoactive factors. Curr Med Chem Cardiovasc Hematol Agents. 2004;2(3):197-200. https://doi.org/10.2174/1568016043356255
  2. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm. 2006;74:443-77.
  3. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;60(3):349-56. https://doi.org/10.1079/PNS2001110
  4. Ndisang JF. Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity. Mediators Inflamm. Epub. 2010.
  5. 조호근, 양정민, 김동일. 麻黃의 투여가 비만 유발 쥐의 생리기능과 DNA chip은 통한 유전자 발현에 미치는 영향에 대한 연구. 대한한방부인과학회지. 2007;20(3):65-80.
  6. 장현준, 이향숙, 이준무. 하고초, 감국, 갈근 약침이 비만쥐의 지질강하, 항산화 효과, TNF-${\alpha}$ IL-6 및 Leptin의 농도와 각종 장기의 해부조직학적 소견에 미치는 영향. 대한경락경혈학회지. 2007;24(4):201-19.
  7. 최은주, 이준무, 원승환, 권기록. 산양산삼약침의 지질강하 및 항산화효과에 대한 생화학적 및 분자생물학적 검토. 대한약침학회지. 2006;9(1):5-20.
  8. 이은. 청각의 지질강하 및 항산화효과. 한국자원식물학회지. 2006;19(5):602-5.
  9. 임상철. 율무추출액이 비만쥐의 지질강하 및 혈당치에 미치는 영향. 한국 자원식물학회지. 2006;19(1):126-9.
  10. 허수영. 비만의 동서의학적 고찰과 치료. 한방재활의학과학회지. 1997;7(1):272-86.
  11. 陳師文. 太平恵民和劑局方. 서울:경희대학교 출판국. 2006:27-8.
  12. 전미혜, 배승희, 신상우, 이영선. 오적산이 자국근종세포의 사멸과 Cell Apoptosis에 미치는 영향. 대한한방부인과학회지. 2003;16(2);45-55.
  13. Buge JA, Austa SD. Edited by Fleicher S, Packer L. Microsomal lipid peroxidation. In: methods in enzymology. London:Academic Press. 1978;52:302-9.
  14. Levander OA, Deloach DP, Morris VC, Moser PB. Platelet glutathione peroxidase activity as an index of selenium status in rats. J Nutr. 1983:55-63, 113.
  15. Flohe L, Becker R, Brigelius R, Lengfelder E, Otting F. Convenient as says for superoxide dismutase. CRC Handbook of free radicals and antioxidants in Biomedicine. 1992:287-93.
  16. Johnson LH, Hakan Borg LA. A spectrophotometric method for determination of catalase activity in small tissue samples. Analytical Biochemistry. 1988:174, 331-6.
  17. AM Seifalian, TD Filippatos, J Joshi, DP Mikhailidis. Obesity and arterial compliance alterations. Curr Vasc Pharmacol. 2010;8(2):155-68. https://doi.org/10.2174/157016110790886956
  18. 국민영양조사보고서. 국민건강보험공단. 2010.
  19. 지식경제부 기술표준원. 제6차 한국인 인체치수 조사사업(Size-Korea 사업)결과 요약. [2010 Dec 17]. Available from:URL:http://www.kats.go.kr/htm/news/report_view.asp?idx_tbl_Gongji=7417&page=1.
  20. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caran M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw, 2006;17(1):4-12.
  21. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111:1448-54. https://doi.org/10.1161/01.CIR.0000158483.13093.9D
  22. Noeman SA, Hamooda HE, Baalash AA. Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats. Diabetol Metab Syndr. 2011;3(1):17. https://doi.org/10.1186/1758-5996-3-17
  23. 洪元稙 譯. 校勘直譯 黃帝內經靈樞. 서울:傳統文化研究會. 1995:284, 388.
  24. 정지행, 정성희, 이종수. 비만에 관한 문헌적 고찰. 동의물리요법과학회지. 1992;2(1):141-55.
  25. 楊維傑. 黃帝內經靈樞譯解. 서울:동양의학연구원출판부. 1980:253, 304, 416.
  26. 傅靑圭, 葉天士. 傅靑圭男女科.葉大士女科. 서울:대성출판사. 1984:106.
  27. 陳貴廷, 楊思澍. 實用中西醫結合診斷治療學. 북경:중국의약과기출판사, 1991:682.
  28. 張介賓, 張氏類經. 서울:成輔社. 1982:586.
  29. 劉河間. 劉河間三六書. 서울:成輔社. 1976:82.
  30. 李東垣. 東垣醫書十種脾胃論. 서울:大星文化史 1983:70.
  31. 진광선. 비만의 연구동향에 대한 분석; 국내 학위 논문 중 한약재에 관한 연구논문을 중심으로. 대진대학교 대학원 석사학위 논문. 2004.
  32. 강경화, 강유식, 이용태. 오적산의 형이상학적 고찰. 동의생리병리학회지. 2004;18(2):389-95.
  33. 한대희, 이학인. 오적산 전탕액이 해열 및 진통에 미치는 영향. 대한한의학회지. 1984;5(1):72-86.
  34. 박종기, 채우석. 오적산 엑기스 과립의 경구 투여와 수침이 동통에 미치는 영향. 대한침구학회지. 1992;9(1):273-91.
  35. 문영희, 박영준. 오적산의 소염 진통효과에 관한 연구. 생약학회지. 1994;25(3):258-63.
  36. 손숙영, 조동현, 두호경. 가미소창음자, 가미 오적산 및 가미보중익기탕이 Gentamicin Sulfate로 유발된 白鼠腎損傷에 미치는 영향. 경희한의대논문집. 1990;13:27-59.
  37. 신규원, 이성동, 박해모, 정성진, 변진석. 다용 한약처방 투여가 흰쥐의 신장기능에 미치는 영향. 대한예방한의학회지. 2005;9(1):119-33.
  38. 서부일, 김미려, 박지하, 지선영. 전탕방법의 변화에 의한 오적산 물추출액이 Hydrocortisone acetate로 유발한 어혈병태에 미치는 효과. 대한외관과학회지. 2001;14(1):182-9.
  39. 김재형, 소경순, 전창길, 김광호. 오적산이 흰쥐의 고지혈증에 미치는 영향에 대한 실험적 연구. 대한예방한의학회지. 2004;8(2):185-202.
  40. 이영종, 손영종, 이은섭, 박중수, 김성기. 비만성 고지혈증 흰쥐에 대한 薏苡仁의 효과. 대한본초학회지. 2004;19(3):129-36.
  41. 임현정, 조금호, 조여원. 고지혈증 환자에서 의학영양치료와 병행하여 섭취한 기능성차 (상엽, 구기자, 국화, 대추, 참깨, 나복자)의 혈중 지질 농도 저하 및 항산화 효과. 한국식품영양과학회지. 2005;34(1):42-56.
  42. 주진만, 김미려, 석장미, 이영선, 박종현. 황기(黃芪) 목통(木通) 복합 추출물이 고지방 식이로 유도된 비만 흰쥐에 미치는 영향. 동의생리병리학회지. 2009;23(3):662-72.
  43. 이장천, 이은, 이영철. 택사농축액이 고지방식이를 급여한 흰쥐의 지진구성 및 TBARS량에 미치는 영향. 대한본초학회지. 2008;23(3):113-7.
  44. 조수열, 김명주, 차전자수침액이 흰쥐의 체내 지질대사에 미치는 영향. 한국식품영양과학회지. 1995;24(4):517-22.
  45. 박경호, 남궁욱, 이영규, 강택림, 김동희. 쥐의 고지방식이로 유발된 병리생리학적 변화에 있어서 청간소요산의 조절효과. 동의생리병리학회지. 2005;19(6):1629-35.
  46. 대한비만학회. 임상비만학. 서울:고려의학. 2001:24-6, 115-6.
  47. Nielsen S, Jensen MD. Obesity and cardivascular disease is body structure a factor. Curr Opin Lipidol. 1997;8(4):200-4. https://doi.org/10.1097/00041433-199708000-00002
  48. 이귀녕, 권오헌. 임상병리파일. 서울:의학문화사. 2000:148, 155-6, 164-5, 169-171, 182, 717.
  49. 李三悅, 權五憲, 鄭允燮, 宋慶順. 임상병리검사법. 서울:연세대학교출판부. 1996:264, 283, 315.
  50. Bruce AF, James D, Carpo MD. Biology of disease: Free radicals and tissue injury. Lab Invest. 1982;47:412-26.
  51. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 2003;88:4673-6. https://doi.org/10.1210/jc.2003-030202
  52. Mizuno T, Matsui H, Imamura A, Numaguchi Y, Sakai K, Murohara T, Okumura K. Insulin resistance increases circulating malondialdehyde-modified LDL and impairs endothelial function in healthy young men. Int J Cardiol. 2004;97:455-61. https://doi.org/10.1016/j.ijcard.2003.10.035
  53. Carantoni M, Abbasi F, Warmerdam F, Klebanov M, Wang PW, Chen YDI, Azhar S, Renven GM. Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers. Arterioscler Thromb Vasc Biol. 1998;18:762-7. https://doi.org/10.1161/01.ATV.18.5.762
  54. Hirai N, Kawano H, Hirashima O, Motoyama T, Moriyama Y, Sakamoto T, Kugiyama K, Ogawa H, Nakao K, Yasue H. Insulin resistance and endothelial dysfuction in smokers: effects of vitamin C. Am J Physiol Heart Circ Physiol. 2000;279:H1172-8. https://doi.org/10.1152/ajpheart.2000.279.3.H1172
  55. Hirashima O, Kawano H, Motoyama T, Hirai N, Ohgushi M, Kugiyama K, Ogawa H, Yasue H. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol. 2000;35:186-90.
  56. Lioyd D. How to avoid oxygen. Science. 1999:286, 249. https://doi.org/10.1126/science.286.5438.249
  57. Singh RJ, Goss SPA, Joseph J, Kalyanaraman B. Nitration of gamma-tocopherol and oxidation of alpha-tocopherol by copper-zinc superoxid dismutase/$H_2O_2$: role of nitrigen dioxide free radical. Natl Acad sci. 1988;95(22):12912-7.
  58. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DC, Hoekstra WG. Biochemical role as a component of glutathione peroxidase. Science. 1973:179, 588. https://doi.org/10.1126/science.179.4073.588
  59. Kesavulu MM, Giri R, Kameswara Rao B, Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics With microvascular complications. Diabetes Metab. 2000;26(5):387-92.
  60. Kono Y, Fridovich I. Superoxide radical inhibits catalase. J Biol Chem. 1982;257(10):5751-4.
  61. Weigle DS. Appetite and the regulation of body composition. FASEB J. 1994;8(3):302-10. https://doi.org/10.1096/fasebj.8.3.8143936
  62. Nielsen S, Jensen MD. Obesity and cardiovascular disease is body structure a factor. Curr Opin Lipidol. 1997;8(4):200-4. https://doi.org/10.1097/00041433-199708000-00002
  63. Kissebah AH, Alfarsi S, Adams PW, Wynn V. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia. 1976;12(6):563-71. https://doi.org/10.1007/BF01220632
  64. Mohamed-Ali V, Goodrick S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-${\alpha}$, in vivo. J Clin Endocrinol Metab. 1997;82:4196-200. https://doi.org/10.1210/jc.82.12.4196
  65. Mohamed-Ali V, Goodrick S, Coppack SW. Adipose tissue an as endocrine and paracrine organ. Int J Obes. 1998;22:1145-58. https://doi.org/10.1038/sj.ijo.0800770
  66. 양정화. 조릿대 잎 추출물이 고지방식이 유도 비만마우스의 (C57/BL6J) 염증성 사이토카인과 인슐린 저항성에 미치는 영향. 전남대교육대학원. 석사학위논문. 2008.
  67. Vance DE, Vance JE. In Biochemistry of Lipids, Lipoprotein & membrance. USA: Elsevier Science Publing Co. 1991:403-85.
  68. Considine RV, Sinha MK, Heiman ML. Serum immunoreactive leptin concentration in normal-weight and obese humans. N Engl J Med. 1996;334:292-5. https://doi.org/10.1056/NEJM199602013340503
  69. Park JH. Insulin resistance in non-alcoholic fatty liver disease. J Korean hepatology. 2006;12(1):16-30.